Figure 3
From: AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment
Quantitative analysis of Ki-67 immune-histochemical results. Quantitative analysis of the immunohistochemical results depicting the differences in the expression of Ki-67 in 3D tissue cultures treated with different drug combination or medium without drugs as control (non-treated) at epidermal/dermal junction site (A) and in dermal stratum (B). Results are expressed in percentage of immune-stained cells with respect to control. **p ≤ 0.01vs control.